Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IGFBP3 |
| Upstream (Parents) |
|---|
| (<<) AKAP12 → IGFBP3 |
| (<<) CTSF → IGFBP3 |
| (<<) EFEMP2 → IGFBP3 |
| (<<) GNAI1 → IGFBP3 |
| (<<) IL1R1 → IGFBP3 |
| (<<) KLF11 → IGFBP3 |
| (<<) NNMT → IGFBP3 |
| (<<) NR3C1 → IGFBP3 |
| (<<) PCK2 → IGFBP3 |
| (<<) ST3GAL1 → IGFBP3 |
| (<<) ST3GAL6 → IGFBP3 |
| Downstream (Children) |
|---|
| IGFBP3 → ARHGAP10 (>>) |
| IGFBP3 → ARSD (>>) |
| IGFBP3 → BMP1 (>>) |
| IGFBP3 → DPH2 (>>) |
| IGFBP3 → DUSP10 (>>) |
| IGFBP3 → E2F2 (>>) |
| IGFBP3 → FUT1 (>>) |
| IGFBP3 → FZD4 (>>) |
| IGFBP3 → GNB5 (>>) |
| IGFBP3 → GRIN1 (>>) |
| IGFBP3 → GRK6 (>>) |
| IGFBP3 → GULP1 (>>) |
| IGFBP3 → ICAM1 (>>) |
| IGFBP3 → IFITM3 (>>) |
| IGFBP3 → IGFBP4 (>>) |
| IGFBP3 → ODC1 (>>) |
| IGFBP3 → PALM (>>) |
| IGFBP3 → PDE2A (>>) |
| IGFBP3 → PELO (>>) |
| IGFBP3 → PIK3R1 (>>) |
| IGFBP3 → PLCG2 (>>) |
| IGFBP3 → PPAP2A (>>) |
| IGFBP3 → PPP1CA (>>) |
| IGFBP3 → PPP2R5B (>>) |
| IGFBP3 → RDX (>>) |
| IGFBP3 → RHOB (>>) |
| IGFBP3 → RNF11 (>>) |
| IGFBP3 → RYK (>>) |
| IGFBP3 → THRA (>>) |
| IGFBP3 → TRIB3 (>>) |
| IGFBP3 → TYK2 (>>) |
| IGFBP3 → WWTR1 (>>) |
